A Comparative Study On 136 Opioid Abusers In India and Nepal
DOI:
https://doi.org/10.3126/jpan.v2i2.9719Keywords:
Opioid abuse, Buprenorphine abuse, IDU, Opioid withdrawal delirium, Koro, India, NepalAbstract
Background: Though opioid abuse is a common clinical entity, only few published articles are available in Nepal.
Aim: To compare the pattern of drugs and opioid abuse amongst patients at two de-addiction centres in India and Nepal
Methods: Seventy-six opioid abusers at CIP, Ranchi, India and 60 opioid abusers at UCMS, Bhairahawa, Nepal were recruited for the present study. Demographic and clinical profiles of patients at these two places are studied and compared.
Results: Mean age of patients at Bhairahawa, Nepal was significantly lower than their counterpart in Ranchi. While majority of patients at Ranchi reported alone for treatment, patients at Bhairahawa were mostly accompanied by their guardians/relatives or friends. Patients at Ranchi had more lifetime diagnosis of opioid abuse while patients at Nepal had more lifetime diagnosis of poly-substance abuse. Patients at Bhairahawa, Nepal had significantly more history of Injectable drug abuse and had more history of IDU related side effects. Approximately 40% of opioid abusers in Nepal centre responded that the opportunity to work abroad was the highest motivating factor for seeking treatment. Opioid withdrawal delirium appeared to a valid clinical entity with history of 5 cases and 2 cases of withdrawal delirium in Ranchi and Bhairahawa center respectively. Symptom of "Koro" during opioid withdrawal period was reported by at least one patient each at Ranchi and Nepal center.
Conclusions: Opioid abusers at both the centres appear to have similar social and clinical characteristics except on few social and clinical parameters.
DOI: http://dx.doi.org/10.3126/jpan.v2i2.9719
J Psychiatrists’ Association of Nepal Vol.2, No.2, 2013 11-17
Downloads
Downloads
Published
How to Cite
Issue
Section
License
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.